VEGFA and cancer: The exacerbated lung metastasis and death after the interruption of antibody treatment was the result of monocyte release from the bone marrow and enhancement of cancer cell mobilization from the primary tumor as well as blood vessel formation and increased proliferation of metastatic cells in the lungs in an IL-6- and VEGF-A-dependent manner.